Strength and opportunity 2015: the landscape of the medical technology and biopharmaceutical sectors in the UK
- Document type
- Corporate author(s)
- Great Britain. Dept. for Business, Innovation and Skills
- Date of publication
- 8 May 2016
- Trends: economic, social and technology trends affecting business
- Business and management
- Material type
This report identifies the strengths in the UK health life sciences industry and the opportunities for future growth.
The three main measures of economic contribution and industry structure are:
- employment – the number of people employed by life science companies;
- turnover – the amount of money taken by businesses within scope of life science sector activities; and
- number of companies – the number of life science companies registered in the UK.
There are significant levels of health life sciences employment. Almost 222,000 people are employed in 5,633 companies generating approximately £60.7bn turnover.
This breaks down into:
- 107,000 employed in the biopharmaceutical sector and service and supply chain in 1,948 companies, generating £39.7 billion turnover;
- 115,000 employed in the medical technology sector and service and supply chain in 3,685 companies, generating £21 billion turnover.
- The digital health sector has an estimated turnover of £886m and approximately 7,400 employees.The digital health sector is the fastest growing sector for employment with 23% annual growth rate over the last 5 years.
Related to Trends: economic, social and technology trends affecting business
Downloadable briefing note looking at the relationship between productivity and pay growth
Downloadable paper on ensuring a fair future of work for women
Downloadable paper on how economic insecurity is experienced by workers
Downloadable briefing note on recent changes to England's apprenticeships system
Related to BIS
This independent review jointly commissioned by The Department for Business, Innovation and Skills (“BIS”) and the Department for Culture, Media and Sport (DCMS) assesses the consumer protection measures
This equality analysis considers the impacts of the postgraduate master’s loans policy on protected and disadvantaged groups. It outlines these impacts, based on a review of the available research and
This report was commissioned by the Department for Business, Innovation and Skills (BIS) following the publication of the fourth (and final) stage of the Futuretrack study in November 2012.The
This report presents the findings from a Youthsight research commissioned by the Department for Business Innovation and Skills (BIS) to collect opinions from a sample of undergraduates and postgraduates